Tarah Auguste, Nurse Practitioner - Adult Health Medicare: Medicare Enrolled Practice Location: 14711 227th St, Sprngfld Gdns, NY 11413 Phone: 917-325-0696 |
News Archive
Cardiac Science Corporation, a global leader in automated external defibrillator and diagnostic cardiac monitoring devices, today announced the introduction of two new products that extend its market-leading position in the cardiac stress test category.
Inducing biological tissue damage with an atmospheric pressure plasma source could open the door to many applications in medicine
Halozyme Therapeutics, Inc. today announced the issuance of U.S. Patent No. 7,767,429 claiming its proprietary recombinant human hyaluronidase enzyme platform (rHuPH20). Claims to the human PH20 glycoprotein, PEGylated variants, the glycoprotein produced by recombinant methods, and pharmaceutical compositions with other agents, including antibodies, insulins, cytokines, anti-infectives and additional therapeutic classes were awarded in the '429 patent. Additional claims are in prosecution.
Future Science OA, the inaugural gold open access journal from Future Science Group, has demonstrated its quality and commitment to openness in being accepted for indexing by the Database of Open Access Journals (DOAJ). In addition, it has been awarded the DOAJ seal, which is awarded to those journals that achieve a high level of openness, adhere to best publishing practice and have high publishing standards.
A new study may alleviate concerns regarding increased cancer risk for patients undergoing spinal fusion surgery with recombinant human bone morphogenetic protein (rhBMP). The study appears in November 15 issue of Spine, published by Wolters Kluwer.
› Verified 1 days ago